Exact Sciences Corporation
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated wit…
Medical - Diagnostics & Research
US, Madison [HQ]
Similar Stocks · Benchmarked Analysis · Peer Group
Peer Group Analysis
Similar Stocks · Benchmarked Analysis · Peer GroupA quick analysis that compared Exact Sciences Corporation (EXAS) to it's peer group, including competitors as well as it's industry. All monetary values in mil. except volume - volume is in thousands.
| Company | Price | Change | Volume, Avg. | Market Cap. | Revenue | Profit Net | Earnings | Free Cash Flow | Dividend Yield | P/E | EPS | Gross Margin % | Net Margin % | ROE % | ROA % | Quick Ratio % | Shares Outstanding | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diagnostics & Research Average | - - | - - | - - | 42,619.49 | 5,186.10 | 229.85 | 9,497.16 | 51.76 | 0.00 | -3.4126 | 46.48 | 0.4078 | -0.0622 | 0.00 | 0.05 | 1.8581 | - - | ||
| Maximum | - - | - - | - - | 916,755.00 | 59,467.00 | 2,293.00 | 94,270.00 | 922.00 | 0.03 | 193.1841 | 880.40 | 1.0000 | 0.2192 | 0.06 | 0.58 | 5.1261 | - - | ||
| Minimum | - - | - - | - - | 0.00 | 0.00 | -31.00 | -2,079.00 | -981.00 | 0.00 | -515.5998 | -1.93 | -0.1974 | -2.1105 | -0.28 | -0.07 | 0.0000 | - - | ||
| Charles River Laboratories International, Inc. CRL | 186.10 | -1.81 -0.96% | 657 vs. 662 | 9,516.00 | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | 51.00 | ||
| Danaher Corporation DHR-PB | 1261.26 | -9.94 -0.78% | 152 vs. 12 | 916,755.00 | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | 726.00 | ||
| Natera, Inc. NTRA | 175.00 | -1.61 -0.91% | 1,534 vs. 1,218 | 23,103.00 | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | 132.00 | ||
| Exact Sciences Corporation EXAS | 56.50 | -0.18 -0.32% | 2,305 vs. 2,381 | 10,456.00 | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | 185.00 | ||
| Illumina, Inc. ILMN | 136.69 | -2.99 -2.14% | 1,485 vs. 1,979 | 21,679.00 | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | 158.00 | ||
| Thermo Fisher Scientific Inc. TMO | 542.84 | -2.09 -0.38% | 2,453 vs. 1,813 | 207,636.00 | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | 382.00 | ||
| Guardant Health, Inc. GH | 36.70 | 0.12 0.31% | 2,749 vs. 1,817 | 4,535.00 | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | 123.00 | ||
| Agilent Technologies, Inc. A | 137.50 | 0.51 0.37% | 1,069 vs. 1,727 | 39,270.00 | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | 285.00 | ||
More Due Diligence
Leverage our visualization and data tables to compare over 25 years of financial data for AAPL and its peers.